Explain the topic ultrasound in pregnancy for obg

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Good — I have clear paths to the key sections. Let me now read the main obstetric ultrasound content in parallel.
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content. Let me also quickly pull the first-trimester ultrasound section and the Doppler section.
Reading File
Reading File
I now have comprehensive content from the textbooks. Let me compile a thorough OBG-oriented explanation.

Ultrasound in Pregnancy — OBG Overview

Source: Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice; Berek & Novak's Gynecology

1. Introduction & Safety

Obstetric ultrasound is the primary imaging modality in pregnancy. It is non-ionizing and has an extensive safety record when used with proper clinical indication. It uses high-frequency sound waves reflected from tissues to generate real-time images. The ALARA ("as low as reasonably achievable") principle applies — output should be minimized while achieving diagnostically adequate images.

2. Types of Obstetric Ultrasound Examinations

Examinations are categorized by clinical indication and level of detail:
CPT CodeExamination TypeDescription
76801First trimester (< 14 weeks), transabdominalRoutine first-trimester screening
76805Standard (≥ 14 weeks)Midtrimester anatomy scan — fetal size, anatomy, placenta
76811Detailed fetal anatomic examFor high-risk cases; performed once per pregnancy per practice
76815LimitedAnswers a discrete question (fetal heart activity, placental location, AFI)
76816Follow-upRepeat exams — growth reassessment, organ re-evaluation
76817TransvaginalAny gestational age via TVS
76818/76819Biophysical Profile (BPP)With or without nonstress test

3. First-Trimester Ultrasound (< 14 Weeks)

Key Objectives

  • Confirm intrauterine pregnancy and exclude ectopic
  • Establish gestational age — crown-rump length (CRL) is the most accurate biometric parameter in the first trimester
  • Determine fetal cardiac activity
  • Assess fetal number and chorionicity in multiples (most accurately determined before 14 weeks)
  • Nuchal translucency (NT) measurement at 11–13+6 weeks for Down syndrome and other aneuploidies screening
  • Detect major structural anomalies (with emerging evidence for late first-trimester detailed scans)

Crown-Rump Length (CRL)

  • Most reliable dating method; accurate to ±5–7 days
  • Obtained in a true neutral position — fetus neither hyperflexed nor hyperextended

Nuchal Translucency

  • The fluid-filled space at the back of the fetal neck
  • NT ≥ 3.0 mm is associated with increased risk of trisomy 21, 18, 13, cardiac defects, and other structural anomalies
  • Combined with serum free β-hCG and PAPP-A (combined first-trimester screening) for detection rates of ~85–90%

4. Midtrimester Anatomy Scan (18–22 Weeks) — The "Anatomy Scan"

This is the most important routine obstetric ultrasound examination. It serves as a major checkpoint for:
  • Confirming/correcting gestational age by comparing obstetric dates with fetal biometry
  • Detecting structural anomalies before fetal viability
  • Identifying placental abnormalities (previa, accreta spectrum)
  • Detecting uterine abnormalities (fibroids, etc.)
Studies show that a scan at 18–20 weeks detects major structural anomalies in approximately 60% of cases in unselected populations (Gagnon et al.).

Fetal Biometry (Standard Measurements)

MeasurementAbbreviationPlane
Biparietal diameterBPDAxial transthalamic plane
Head circumferenceHCSame axial plane
Abdominal circumferenceACAxial plane at stomach/umbilical vein
Femur lengthFLLong axis of femur
These four measurements are used to calculate Estimated Fetal Weight (EFW) and gestational age.
Head circumference (HC) and BPD measurement
Figure: Head circumference (HC) and BPD measurement

Detailed Fetal Anatomy Checklist (CPT 76805)

Head & Face
  • Cranial bones, falx cerebri, cavum septi pellucidi
  • Thalami, lateral ventricles (normal < 10 mm)
  • Cerebellum, cisterna magna
  • Orbits, facial profile, nasal bone, upper lip
Cavum septum pellucidum
Figure: Cavum septum pellucidum (arrow)
Posterior fossa — cerebellum and nuchal fold
Figure: Posterior fossa — cerebellum and nuchal fold measurement
Thorax
  • Four-chamber view of the heart
  • Cardiac axis (normally ~45° to the left)
  • Left and right ventricular outflow tracts
  • Lung parenchyma
Four-chamber heart view
Figure: Four-chamber heart view in diastole and systole (RV, LV, RA, LA)
Left ventricular outflow tract
Figure: Left ventricular outflow tract
Abdomen
  • Stomach (should be visible and fluid-filled)
  • Abdominal umbilical cord insertion
  • Kidneys and bladder
  • Umbilical arteries (should be two)
Spine & Extremities
  • Spine in longitudinal and transverse views
  • All four extremities (upper and lower long bones)
  • Hand/foot anatomy and posture
  • Genitalia
Fetal nasal bone
Figure: Fetal profile with nasal bone (marker for Down syndrome screening)

Placenta, Cord & Amniotic Fluid

Placenta:
  • Location (note if low-lying or previa)
  • Appearance (masses, cysts, lucencies, accessory lobe)
  • Umbilical cord insertion site (central/marginal/velamentous)
  • Number of umbilical cord vessels (normally 3 — 2 arteries + 1 vein)
Amniotic Fluid Volume:
  • Maximum Vertical Pocket (MVP): Normal 2–8 cm
  • Amniotic Fluid Index (AFI): Sum of MVPs in four quadrants; normal 5–24 cm
  • Oligohydramnios: MVP < 2 cm / AFI < 5 cm
  • Polyhydramnios: MVP > 8 cm / AFI > 24 cm

5. Third-Trimester Ultrasound — Growth & Well-being

Fetal Growth Assessment

  • Serial biometry every 3–4 weeks in growth-restricted fetuses
  • EFW < 10th percentile = small for gestational age (SGA); EFW < 3rd percentile = severely growth-restricted

Biophysical Profile (BPP)

Assesses fetal well-being by scoring five parameters (2 points each, maximum score = 10):
ParameterNormal (Score 2)
Fetal breathing movements≥ 1 episode lasting ≥ 30 seconds in 30 min
Gross body movements≥ 3 discrete movements in 30 min
Fetal tone≥ 1 extension/flexion cycle
Amniotic fluid volumeMVP ≥ 2 cm
Non-stress test (NST)Reactive (in BPP with NST, CPT 76818)
Score ≥ 8/10 is reassuring; score ≤ 4/10 warrants delivery or intensive monitoring.

6. Doppler Velocimetry

Doppler ultrasound evaluates blood flow velocity waveforms in fetal and maternal vessels. It is essential for monitoring feto-placental compromise in fetal growth restriction (FGR) and preeclampsia.

Umbilical Artery (UA) Doppler

  • Reflects placental vascular resistance
  • Normal: diastolic flow present and progressive throughout pregnancy
  • Abnormal patterns (in order of severity):
    1. Elevated S/D ratio / increased PI, RI — increased resistance
    2. Absent End-Diastolic Velocity (AEDV) — critical worsening
    3. Reversed End-Diastolic Velocity (REDV) — imminent fetal compromise; strong indicator for delivery
Umbilical artery Doppler waveforms
Figure: Progressive umbilical artery resistance — from nearly normal at 18 weeks to absent end-diastolic velocities at 24 weeks

Middle Cerebral Artery (MCA) Doppler

  • Measures MCA Peak Systolic Velocity (PSV)
  • Brain-sparing effect: in FGR, MCA resistance decreases (vasodilation) as the fetus preferentially perfuses the brain
  • MCA PSV > 1.5 MoM (multiples of the median): hallmark for fetal anaemia (e.g., Rh isoimmunization, hydrops fetalis)

Ductus Venosus (DV) Doppler

  • Reflects right heart pressure and venous return
  • Absent or reversed a-wave in DV waveform = sign of severe cardiac compromise; indicates imminent fetal acidosis and guides timing of delivery in preterm FGR

7. Cervical Length Assessment

  • Transvaginal ultrasound (TVS) is the standard method
  • Short cervix (< 25 mm before 24 weeks) predicts preterm birth
  • Used to guide decisions on:
    • Cervical cerclage
    • Progesterone supplementation
    • Antenatal corticosteroids

8. Ultrasound Markers for Aneuploidy

First Trimester Markers

MarkerAssociation
↑ Nuchal Translucency (≥ 3.0 mm)Trisomy 21, 18, 13; cardiac defects; Turner syndrome
Absent nasal boneTrisomy 21
Reversed ductus venosus a-waveTrisomy 21, cardiac defects
Tricuspid regurgitationTrisomy 21

Second Trimester "Soft Markers"

MarkerMain Association
Choroid plexus cystsTrisomy 18
Echogenic intracardiac focusTrisomy 21
Nuchal fold ≥ 6 mmTrisomy 21
Short femur/humerusTrisomy 21
PyelectasisTrisomy 21
Echogenic bowelTrisomy 21, CF, CMV

9. Special Applications

Multiple Pregnancy

  • Chorionicity determination is critical and most accurately assessed at < 14 weeks:
    • Dichorionic-diamniotic (DCDA): "Twin peak" (lambda sign) — triangular wedge of placental tissue between membranes
    • Monochorionic-diamniotic (MCDA): "T-sign" — membrane inserts at right angle to placenta
  • Ultrasound staging of Twin-Twin Transfusion Syndrome (TTTS) using Quintero criteria (based on UA, UV, DV Doppler and amniotic fluid discordance)
  • Detection of Selective FGR in monochorionic twins

Placental Abnormalities

  • Placenta previa: Placenta covering the internal os — typically confirmed by TVS at 32–36 weeks
  • Placenta accreta spectrum: Abnormal placentation suspected on grey-scale and colour Doppler — loss of retroplacental clear space, placental lacunae, bridging vessels to bladder

10. Reporting Requirements

Every obstetric ultrasound report must include:
  • Patient identifying information and date
  • Indication for the procedure and type of examination
  • Gestational age by established dates
  • Number of fetuses (and chorionicity if multiples)
  • Fetal biometry with predicted gestational age
  • Principal findings (normal, abnormal, or poorly visualized)
  • Differential diagnosis for abnormalities
  • Recommendations for management or follow-up

Summary Table: Ultrasound Schedule in Normal Pregnancy

TimingExaminationKey Parameters
7–10 weeksEarly pregnancyConfirm IUP, CRL, cardiac activity, number
11–13+6 weeksNT scanNT, nasal bone, CRL, chorionicity
18–22 weeksAnatomy scan (level II)Full fetal anatomy, biometry, placenta, AFI
28–32 weeksGrowth scanBiometry, EFW, AFI, presentation
36+ weeksTerm scanPresentation, AFI, BPP if indicated
Any trimesterDopplerUA, MCA, DV when FGR or anaemia suspected

Sources: Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice (9780323828499), pp. 318–335; Berek & Novak's Gynecology (9781496380357)
This is a shared conversation. Sign in to Orris to start your own chat.